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All multicellular organisms are exposed to a diversity of infectious agents and to the emergence and 
proliferation of malignant cells. the protection conferred by some infections against cancer has been 
recently linked to the production of acquired immunity effectors such as antibodies. However, the 
evolution of innate immunity as a mechanism to prevent cancer and how it is jeopardized by infections 
remain poorly investigated. Here, we explored this question by performing experimental infections 
in two genetically modified invertebrate models (Drosophila melanogaster) that develop invasive or 
non-invasive neoplastic brain tumors. After quantifying tumor size and antimicrobial peptide gene 
expression, we found that Drosophila larvae infected with a naturally occurring bacterium had smaller 
tumors compared to controls and to fungus-infected larvae. This was associated with the upregulation 
of genes encoding two antimicrobial peptides—diptericin and drosomycin—that are known to be 
important mediators of tumor cell death. We further confirmed that tumor regression upon infection 
was associated with an increase in tumor cell death. Thus, our study suggests that infection could 
have a protective role through the production of antimicrobial peptides that increase tumor cell death. 
Finally, our study highlights the need to understand the role of innate immune effectors in the complex 
interactions between infections and cancer cell communities in order to develop innovative cancer 
treatment strategies.
The bodies of virtually all multicellular organisms can be considered as holobionts that are composed—in addi-
tion to host cells—of a diversity of living entities, including microbiota, parasites, and malignant cells1. While 
reciprocal interactions between host phenotype and symbiotic organisms have long fascinated evolutionary 
ecologists2–6, oncogenic phenomena have scarcely been considered as potential players in these interactions7,8. 
Nevertheless, malignant cells have been omnipresent in the bodies of multicellular organisms for more than half 
a billion years9, and not only in post-reproductive stages10. They are furthermore involved in reciprocal interac-
tions with microbes and parasites11, hence setting the scene for fascinating, yet complex, tripartite interactions. 
Understanding these interactions is an emerging and relevant topic in ecology and evolution since any pheno-
typic change related to health, however small, can be associated in the wild with a higher risk of predation and/or 
infection as well as reduced competitiveness/attractiveness in sexual selection processes12.
The indirect role of infections on tumor dynamics has been recently reviewed, highlighting the importance 
of immune responses in explaining the protection conferred by certain infectious agents13. Indeed, numerous 
immune mechanisms are shared by anti-infection and anti-cancer responses14, and the impact of infectious 
agents on tumoral immunity has been studied in mammal models. For instance, tumor regression following 
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Bacille Calmette Guerin (BCG) vaccination has been linked with the infiltration of BCG-specific T cells into the 
tumor15. In addition, it has been shown that influenza-experienced mice control lung tumor challenge better than 
naïve mice through the generation of antibodies specific to the antigens shared by both infected and cancer cells16. 
Epidemiological studies have shown that antibodies against tumor-associated antigens can be found in patients 
who experienced a large number of acute infectious or inflammatory events early in life and who had a drastically 
reduced risk of ovarian cancer later in life17–19.
We see that the role of adaptive immunity, specific to infectious antigens and providing long-lasting responses, 
has been well-described in terms of cancer protection conferred by exposure to infections. However, early work 
by William Coley20 as well as recent reports in mice21 have unambiguously suggested that innate immunity, i.e., 
a non-specific defense that comes into play immediately or within hours of an antigen’s appearance, may be 
particularly relevant when trying to understand the interactions between infections and cancer21–23. Because it 
is technically challenging to create mammal models totally deprived of adaptive effectors, the use of an inverte-
brate model that does not evolve adaptive immunity (but see24,25 for evidence of immune memory) could bring 
new and relevant findings to this compelling topic. Since neoplastic lesions have been reported in a wide range 
of invertebrates from hydra to starfish26,27, and because those organisms only harbor innate immune effectors, 
natural selection may have selected them to eliminate aberrant cells. Nevertheless, the role of infectious pressures 
on tumor development in invertebrates has been poorly investigated, with the exception of studies on infectious 
neoplasia28.
To disentangle the role of infection-induced innate immunity in tumor burden, we thus used Drosophila, 
which is recognized as a pertinent model for the study of cancer29. In Drosophila, the production of antimicrobial 
peptides (AMP) is an important aspect of host defense. They are synthetized by the fat body (a multifunctional 
tissue involved in immune responses, energy storage, and nutritional sensing) in response to infections and cir-
culate in the blood. These peptides can be grouped into three families based on their main biological targets, 
i.e., gram-positive bacteria (defensin), gram-negative bacteria (cecropins, drosocin, attacins, diptericin), or fungi 
(drosomycin, metchnikowin)30. Another type of host defense mechanism to injury, parasitoid wasp infection, or 
aberrant cells is the activation of the Janus Kinase/Signal Transducer and Activator of Transcription (Jak/STAT) 
pathway31–33. Interestingly, Jak-STAT has been shown to regulate AMP production in response to damage and 
stress but not microbial products34. Thus, we carried out two types of acute infection, one with a gram-negative 
bacterium and the other with a fungus, on an experimental model that develops GFP-labeled invasive neoplastic 
tumors in a larval epithelial tissue called the eye-antennal disc35. Extensive image analysis of the tumors and tran-
scriptomic study of two main AMP genes and of an activator of the Jak-STAT pathway allowed us to hypothesize 
the role of infection in tumor regression. Using an independent tumor model, we then confirmed tumor regres-
sion following bacterial infection and suggest that this decrease is, at least in part, due to an increase of tumor cell 
death that could be mediated by the AMP production.
Results
Innate immune responses to tumor cells and impact of infections on tumor size. Our scrib1/
RasV12 mutant model allows visualization of the tumor in vivo in late 3rd instar larvae using a dissecting micro-
scope under GFP fluorescence (Fig. 1A,B). We first measured activation of the innate immunity in non-infected 
cancerous larvae. qRT-PCR analyses revealed that scrib1/RasV12 mutants showed higher levels of drosomycin (drs) 
gene expression than non-cancerous larvae (Fig. 1C; p = 0.0003). However, we did not find increased gene expres-
sion of diptericin (dpt) or of the cytokine unpaired 3 (upd3, a key activator of the Jak/STAT pathway). This sug-
gests that the presence of tumor cells could induce activation of the drs gene in the fat body or in the circulating 
hemocytes.
To test whether drs activation was a protective mechanism against cancer, we measured the effect of different 
infectious treatments on tumor size in our Drosophila model. We compared tumor growth in non-infected larvae 
and in larvae infected by the gram-negative bacterium Pectobacterium carotovorum carotovorum (Pcc) or by the 
fungal entomopathogen Beauvaria bassiana (Bb), both known to strongly stimulate AMP production36. Analysis 
of tumor phenotype showed that larvae orally infected by the Pcc bacterium showed a 20% decrease in tumor size 
compared to uninfected ones (Fig. 1D; p = 0.004) and Bb infected ones (p = 0.026). This was also true when con-
sidering a more restricted threshold of detection (Figure S1; Supplementary materials). Infection by Bb did not 
significantly affect tumor size compared to controls. We also confirmed that the dose used to induce infections 
did not cause a delay in development, which could impact tumor size, and showed that the body size of infected 
larvae is similar to that of uninfected larvae (Fig. 1E). In addition, the lack of correlation between body size and 
tumor size in bacterial-infected larvae suggests that cancerous larvae with large tumors were not more susceptible 
to the infection (Figure S2, Supplementary materials).
We therefore further analyzed AMP production following bacterial infection in an attempt to explain its spe-
cific impact on tumor size, looking for mechanisms that would not occur with a fungal infection.
innate immune responses to infections and function of dpt in tumor regression. To identify 
which AMP plays a role in the specific effect of bacterial infection on tumor regression, we studied the upregu-
lation of AMP genes following infections in cancerous larvae. On the one hand, infection with Pcc resulted in a 
50-fold increase of dpt mRNA expression compared to non-infected larvae (Fig. 2A; p < 0.0001) as well as in an 
increase of drs expression (p = 0.024). The same analyses were conducted in non-cancerous larvae, and we found 
that the bacterial infection also upregulated dpt gene expression (Fig. 2B; p < 0.0001). However, contrary to what 
was observed in cancerous larvae, drs gene expression was found to be upregulated not only following bacterial 
infection (p = 0.006) but also following fungal infection (Fig. 2B; p = 0.003).
To determine whether AMP production could result from cell damage that was induced either by the infec-
tion or by immune responses (in a manner independent of microbial products), we measured gene expression 
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of cytokine upd3 and found that it was downregulated in bacterial-infected cancerous larvae (Fig. 2A; p = 0.016) 
and non-cancerous larvae (Fig. 2B; p = 0.014). All together, these data indicate that microbial products from 
Pcc activate the production of dpt and drs, which could increase tumor cell death and thus be involved in tumor 
regression.
Tumor cell death and regression following bacterial infection in dlg40.2 mutants. To further con-
firm that bacterial infection with Pcc and the associated AMP production can trigger tumor regression, we made 
use of dlg40.2 mutants (hereafter referred to as dlg), an independent tumor model leading to the formation of 
non-invasive neoplastic tumors in the wing disc. Using tumor dissection, immunostaining, and confocal imaging 
(Fig. 3A,B), we observed that oral infection of dlg-mutant larvae with Pcc led to strong decreases in tumor volume, 
reaching roughly 38% (Fig. 3C; p < 0.0001). Interestingly, using anti-dcp1 staining as a marker of tumor cell death 
(Fig. 3D,E), we observed a 76% increase in caspase activation (Fig. 3F; p < 0.0001). These results confirm that Pcc 
infection is a robust inducer of tumor regression at least in part through an increase in tumor cell death.
Discussion
Multicellular organisms are not autonomous entities, but rather “holobionts” composed of the host cells, includ-
ing those carrying oncogenic mutations, plus all of its commensal and mutualistic microorganisms as well as a 
diversity of more or less prevalent parasite taxa (viruses, bacteria, fungi, protozoa, and metazoans)1. However, 
triple reciprocal interactions involving malignant cells, infections, and hosts have been until now little studied. In 
this context, our study demonstrates that naturally occurring bacterial infection can promote tumor regression 
in two drosophila tumor models, and it supports the idea that infection-dependent production of diptericin 
and drosomycin, two antimicrobial peptides, may be key drivers of this regression through increased tumor cell 
death. Our results are supported by previous studies showing that increase in Toll and Imd signaling in tissues 
distant from the tumor result in increased tumor cell death in dlg mutant animals37–39. Imd and Toll pathways 
could act synergistically to produce AMP, as already reported elsewhere40. Even if dpt and drs are considered 
Figure 1. Tumor visualization in vivo in (A) non-cancerous and (B) cancerous larvae characterized by GFP-
labeled cells (in white) in the eye-antennal disc region. (C) Fold induction of the three immune genes in 
cancerous larvae (yellow; n = 10 pools) without infection relative to non-cancerous larvae (dark blue; n = 10 
pools). The error bars represent standard deviation (SD) of two independent experiments (***p < 0.001; 
**p < 0.01; *p < 0.05; Sidak’s test). Effect of infection by the bacterium Pectobacterium carotovorum 
carotovorum (Pcc, red; n = 96 total) and the fungi Beauvaria bassiana (Bb, orange; n = 102 total) compared 
to uninfected flies (blue; n = 97 total) on individual tumor size with a low intensity threshold of detection 
(S2 threshold: 75% of maximum intensity value) in three independent experiments. The error bars represent 
standard deviation (***p < 0.001; **p < 0.01; *p < 0.05; NS > 0.05; Tukey’s test). (E) Impact of body size, 
approximated by mouth hook size, on tumor size depending on infectious treatment (n = 20 by infection group; 
error bars are SD).
4Scientific RepoRtS |        (2020) 10:10106  | https://doi.org/10.1038/s41598-020-66813-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
as read-outs of the Imd and Toll pathways, respectively, further studies are needed to assess the regulation of 
pathway-specific genes such as Dif, Dorsal, and Relish and to confirm the involvement of their cross-activation in 
bacterial-induced tumor regression. In addition, we cannot exclude that other mechanisms—such as the tumor’s 
intrinsic activation of immune pathways, which are reported to play a role in cell competition processes41,42, or 
metabolic and/or microbiota alterations consequent to digestive infection—could have also contributed to tumor 
size reduction. Finally, a potential bias could be that larvae with larger tumors experience higher mortality, there-
fore artificially reducing tumor size. However, our observations do not support this, as we were able to show that 
infection by both pathogens and tumor size did not affect body condition (Figure S2).
In scrib1/RasV12 mutants, a local upd3 upregulation has been observed at the tumor site in cancer cells as a 
response to tissue damage31 that can also promote tumor growth43. However, our data suggest that this local 
response is not amplified by the expression of unpaired cytokines in the fat body or the circulating hemocytes. 
The downregulation of upd3 cytokine expression following the infection could represent a negative feedback loop 
to limit the damage associated with the infections. Another interesting result is the absence of tumor regression 
following fungal infection. Fungal infection is generally associated with the production of drs36, as observed in 
our non-cancerous individuals; however, drs expression was not significantly upregulated in cancerous mutants. 
Because drs was high in mutants, it could have impaired the infection. Furthermore, the absence of dpt upregula-
tion could also explain the absence of tumor regression following fungal infection.
This last result indicates that protection against cancer may be conferred only by certain infections, even 
if innate immune effectors are thought to be mainly non-specific. It is likely that the protective mechanisms 
observed in response to Pcc infection will also be induced by other bacteria since they share common antigens 
called pathogen-associated molecular patterns (PAMPs)44. Using the scrib1/RasV12 model, we have been able to 
show that a single bacterial infection can reduce tumor size by at least 20%. However, previous work on mice 
has showed that two immune challenges with influenza viruses could result in a larger reduction in tumor size16. 
More generally, reports from Coley’s experiments as well as the use of bacillus Calmette-Guerin to treat superficial 
bladder cancer have indicated the importance of recurrent infections in promoting efficient tumor regression20,45. 
Because it is experimentally challenging to do repeated infections on a short-lived model like Drosophila larvae, 
Figure 2. (A) mRNA levels of expression for the three AMP genes, dpt, drs, and upd3, in cancerous larvae in 
response to infection by the bacterium Pcc (red; n = 15 pools) and the fungi Bb (orange; n = 14 pools) compared 
to uninfected larvae (Ctl, blue; n = 13 pools). Data shown here were pooled from five independent experiments 
(***p < 0.001; **p < 0.01; *p < 0.05; Kruskal-Wallis test). Gene expression was assessed by qRT PCR with 
the primers described in Table S2. (B) mRNA levels of expression for the three AMP genes (dpt, drs, upd3) in 
non-cancerous larvae following infections (n = 10 pools by infection group). The error bars represent standard 
deviation and data were pooled from two independent experiments (****p < 0.0001; ***p < 0.001; **<0.01; 
*p < 0.05; Kruskal-Wallis test).
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further studies should investigate their impact on innate immunity since it could jeopardize natural anti-tumoral 
responses in vivo in long-living mammalian models.
Because humans, like all organisms, face complex schemes of infections46, consideration of the personal his-
tory of infections in a clinical setting could reveal relevant information for identifying individuals at risk for 
cancer. During the 20th century, radiotherapy and chemotherapy were intensively developed to the detriment 
of early attempts at immunotherapy, such as Coley’s toxin22. However, the striking rise in immunotherapeutic 
strategies over the few past decades, exemplified by the attribution of the 2018 Nobel Prize in Medicine, calls for 
a re-evaluation of mechanisms linking infections and spontaneous tumor regression. While studies have mainly 
focused on adaptive immunity for the elaboration of new drugs47, our study, together with other recent studies 
in flies38,39, has revealed some molecular aspects mediating the forgotten potential of the innate immune system 
in the control of tumor burden. Further efforts should be made to elucidate the precise molecular mechanisms 
leading to cancer regression in response to innate immune system activation: this may also help with the design 
of new therapeutic strategies using drugs that mimic the effect of infections to establish an innate immune profile 
adverse to cancer cells. Our results may also stimulate further studies to explore the links between cancer and 
infections in the wild and how public health strategies targeting transmissible diseases may affect the incidence 
of cancer.
Materials and Methods
tumor model and drosophila stocks. The genetically modified Drosophila melanogaster strain known as 
scrib1/Rasv12 was engineered to develop a tumor of the eye-antennal discs, as previously described elsewhere35. 
Briefly, the genetic scheme uses a truncated eyeless promoter-driven FLP recombinase expression (ey(3.5)-
FLP) to generate discrete patches of GFP-labeled mutant cells specifically in the developing larval eye-anten-
nal discs. Clones are mutant for the cell polarity regulator scribble (scrib) and mis-express a constitutive active 
form of the ras oncogene (Rasv12). Male yw; Sp/Cyo; FRT82B/TM6 flies were crossed with yw, ey(3.5)-FLP; 
Figure 3. (A,B) Representative immunofluorescence images of the tissues quantified in both conditions, 
stained with DAPI (white) to measure tumor volume. Wing discs are highlighted by the yellow dotted 
lines. Scale bars = 50 mm. (C) Quantification of wing disc tumor volumes from uninfected dlg mutant 
larvae (Uninfected, n = 33) or from dlg mutant larvae infected with Pcc (n = 28). (D,E) Representative 
immunofluorescence images of the quantified tissues that have been stained with the anti-Dcp1 antibody (red) 
to measure tumor cell death. F) Quantification of wing disc tumor cell death  in dlg mutant larvae uninfected 
(Uninfected, n = 33) or infected with Pcc (n = 28). Results are presented as a pool of two independent replicates 
(****p < 0.0001; Student’s t-test).
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act5 > stop > gal4,UAS-GFP; FRT82B, Tub-gal80 females to generate non-cancerous larvae (referred to as NC) 
bearing GFP-labeled healthy clones. Male UAS-Ras85Dv12; FRT82B, scrib1 /TM6 were crossed with the same 
females described above to generate cancerous larvae (referred as C) bearing scrib1/Rasv12 GFP-labeled tumors. 
These crosses were allowed to lay eggs on sugar-agar plates for less than 24 h, and collected embryos were incu-
bated for two days at 24 °C. From the two crosses, we selected larvae at the late 2nd or early 3rd instar stage based on 
the lack of the dominant Tubby phenotype carried on the TM6 balancer chromosome. The other fly stock used in 
this study was the dlg40.2/FM7-gfp mutant line48. All drosophila stocks and crosses were maintained on standard 
fly medium under 12 h :12 h light: dark cycles.
infectious agents. Pectobacterium carotovora carotovora Ecc15 (Pcc) is a gram negative bacterium that can 
naturally infect drosophila49; Pcc used in our study was provided by the Pasteur Institut (Reference CIP 82.83 T). It 
was maintained in shaking culture in LB medium at 29 °C. Beauvaria bassiana (Bb) is a naturally occurring insect 
fungus that infects flies during sporulation. Bb was kindly provided by Anna Dostalova (École Polytechnique 
Fédérale de Lausanne, Switzerland). The fungus was grown on malt agar plates at 29 °C in the dark for two weeks.
infecting experiments. For the infection of scrib1/Rasv12, an overnight culture of Pcc was pelleted by cen-
trifugation (15 min at 4500 rpm) and adjusted to OD600 = 200. Infection was done for 4 h at 29 °C by incubating 
larvae with 1.5 mL of bacterial suspension mixed with crushed banana in small petri dishes according to the 
protocol described elsewhere49. For Bb infections, scrib1/Rasv12 larvae were rolled on spores and then incubated 
in spores for 2 h at 29 °C36,50. Larvae were then transferred to crushed banana to avoid a bias caused by the diet 
change and incubated an additional 2 h at 29 °C. These two methods are expected to result in both cutaneous and 
oral infections for Pcc and Bb and therefore maximize the success of infection while mimicking the natural way 
infection occurs. Finally, a scrib1/Rasv12 control group was incubated with crushed banana with no infectious 
agent for 4 h at 29 °C. After incubation, seven larvae were transferred into each well of a 96-well plate filled with 
yeast-sugar-agar medium and wells were plugged. The persistence of the infection was assessed in random groups 
of larvae (without selection for cancerous status) through classical PCR with specific primers (Table S1).
For Pcc infection of dlg mutant larvae, the pelleted bacterial culture was adjusted to OD600 = 200 and then 
mixed 1:1 with a 5% sucrose solution. To set up infectious conditions, 750 μL serial dilutions (1:2 to 1:32) of 
bacterial solution were plated directly into bottles containing fly food, and 200 newly eclosed first instar larvae 
were transferred to the medium. We determined that a 1:16 dilution was the highest concentration that did not 
disrupt larval development (larval size and developmental delay). Larvae were grown for seven days at 25 °C and 
used for tumor analysis. Uninfected larvae were raised on penicillin/streptomycin containing food to avoid any 
bacterial contamination.
Quantification of tumor size. For scrib1/Rasv12, we performed tumor visualization of late 3rd instar larvae 
two days post-infection using a dissecting microscope under GFP fluorescence (Zeiss A Lovert 200 M, 2.5×). 
Tumors were isolated with ImageJ 1.41.0 software51. The intensity values of each pixel were standardized by 
exposure time (see Supplementary materials for more detail). Finally, tumor size was quantified with Matlab 
(MATLAB 2015b, The MathWorks, Natick, MA) as the number of pixels with the scaled intensity above a given 
threshold. Four intensity thresholds were considered to measure tumor size: pixel intensities greater than 50% 
(S1), 75% (S2), 90% (S3), or 95% (S4) of the maximal intensity recorded in the picture (Figure S3). Thus, we 
obtained four distinct tumor measurements standardized by exposure time that were analyzed separately to quan-
tify the robustness of our results (see Supplementary materials for sensitivity on this measure).
For dlg mutant larvae, tumors were dissected in PBS seven days after eclosion, fixed in 4% formaldehyde, and 
immunostained with 4′,6-diamidine-20-phenylindole dihydrochloride (DAPI) (sigma) and rabbit anti-cleaved 
decapping protein 1 (Dcp1) (Cell Signaling Technology) antibody as previously described38. Tissues were imaged 
at optimal slice parameters and 12-bit resolution using a Zeiss 710 confocal microscope. We then used Volocity 
3D imaging analysis software (Perkin Elmer) to quantify total tumor volume identified by DAPI staining and cell 
death visualized with anti-Dcp1 staining, as described in38.
qRT-PCR analysis. After infections and determination of cancerous status, we obtained 10 pools of seven 
larvae for each group (non-infected, Pcc- or Bb-infected larvae) for non-cancerous larvae. We obtained 15 pools 
of seven larvae for each infectious treatment for cancerous larvae. All pools were fixed in liquid nitrogen and 
stored at −80 °C. Total RNA was extracted using a TRIzol reagent following the manufacturer’s protocol. Total 
RNA was eluted in 50 µL of water and 25 µL were used to perform DNase treatment (Turbo DNA-free kit, Life 
Technologies). Finally, total RNA was quantified using Nanodrop (ThermoScientific) and cDNA was synthetized 
from 2.5 µg of total RNA using a SuperScript III kit (SS III First-Strand Synthesis System, Life Technologies) in 
20 µL total volume according to the manufacturer’s instructions.
We quantified the expression levels of the drosomycin (drs), diptericin (dpt), and unpaired 3 (upd3) genes using 
gene-specific primers (see Table S2). PCR reactions were conducted in a total volume of 3 µL with LightCycle ® 
480 SYBR Green I Master (Roche). A 10 min pre-incubation at 95 °C was followed by 40 cycles of amplification: 
10 s at 95 °C, 10 s at 64 °C, and 10 s at 72 °C. Melting curves were generated after the final amplification cycle by 
denaturing the amplicons at 95 °C for 5 s, cooling to 65 °C for 1 min, and then increasing to 97 °C. Melting curves 
were used to estimate the specific melting temperature for each reaction. Each sample (i.e., pool) was analyzed 
in triplicate. The PCR efficiency and threshold cycle (Ct) were calculated using LightCycler ® 480 software. Only 
triplicates with a Ct standard deviation below 0.5 were kept for the following analyses. Threshold cycle values 
were expressed relative to two housekeeping genes (rp49 and tub84b)52 according to the procedure described in53, 
which is based on the common method of 2−ΔΔCt. After normalization and inter-run calibration, we obtained the 
calibrated normalized relative quantity. We also measured the coefficient of variation (CV) and gene stability (M) 
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for reference genes. We found that rp49 and tub84b had a CV of 9.3% and 8.9%, respectively, which are considered 
as acceptable values (i.e., <2553). M was equal to 0.26, which means that our reference genes were stably expressed 
and our samples homogenous.
Statistical analyses. All data are presented as mean ± SD, and the number of individuals are indicated in 
the figure legends. Statistical analyses were carried out using GraphPad Prism7 software, the appropriate statisti-
cal tests were applied, and only significant differences are indicated in the plots.
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